COMMUNIQUÉS West-GlobeNewswire

Olainfarm Starts the Year With 40% Sales Increase

15/02/2019 - 16:26

Consolidated sales – January Preliminary consolidated results of AS Olainfarm for January 2019 show that sales of the Group have reached 12.4 million euros, which represents an increase by 35% compared to sales made in [...]

CTD Announces Appointment of Sharon H. Hrynkow, PhD as Chief Scientific Officer

15/02/2019 - 16:04

ALACHUA, Fla., Feb. 15, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]

Cruzani Returns to QSR Mission

15/02/2019 - 16:00

ATLANTA, Feb. 15, 2019 (GLOBE NEWSWIRE) -- CRUZANI, Inc. (OTC PINK: CZNI), www.CRUZANI.com , a global business development company in the food service sector, announced today that it will be adjusting its subsidiary [...]

Griffin Health launches its frameless SRS program using C-RAD Catalyst HD with cBrain software

15/02/2019 - 15:00

Griffin Health launches its frameless SRS program using C-RAD Catalyst HD with cBrain software C-RAD announced today that the Center for Cancer Care at Griffin Hospital in Derby, CT, in partnership with physicians and [...]

Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for Alzheimer’s Disease

15/02/2019 - 15:00

SOUTH SAN FRANCISCO, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, [...]

Obalon Schedules Fourth Quarter and Year End 2018 Financial Results Conference Call for February 22, 2019 at 8:30 a.m. Eastern Time

15/02/2019 - 15:00

SAN DIEGO, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]

Generex Biotechnology Announces Investor Conference Call Agenda; Tuesday, February 26, at 11:00 A.M. Eastern

15/02/2019 - 15:00

Management to Provide Update on Strategic Acquisitions, Financing, Growth Initiatives & Spin Out of NuGenerex Immuno-Oncology MIRAMAR, FL, Feb. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology [...]

Dragon Jade Enters MOU for Stake in Connaissance Holdings

15/02/2019 - 15:00

HONG KONG, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Dragon Jade International Limited (“Dragon Jade” or “the Company”) (OTCQX: DGJI), today announced that it has entered into a memorandum of understanding (“MOU”) to acquire up [...]

Xbrane Biopharma AB informs about presentations where the company participates on February 19

15/02/2019 - 14:23

Press release 2019-02-15 During Tuesday, February 19, Xbrane will attend two presentations that will also be webcasted live. Below follows information about the events and links to the webcasts that will also be [...]

Extendicare Announces February 2019 Dividend of C$0.04 per Share

15/02/2019 - 14:00

MARKHAM, Ontario, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]

Predictive Technology Group Reports Second Quarter Fiscal 2019 Financial

15/02/2019 - 14:00

Revenue jumps 216% for the quarter to $10.7 million versus the prior year; and up 246% for the six month period to $18.8 million with $2.0 million in positive cash flow from operations SALT LAKE CITY, Feb. 15, 2019 ( [...]

Quotient Limited to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

15/02/2019 - 14:00

JERSEY, Channel Islands, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that today announced that the Company’s Chief Executive Officer, Franz [...]

Hoth Therapeutics Inc. Announces Pricing of Initial Public Offering and Trading on the Nasdaq Capital Market Under the Ticker Symbol “HOTH”

15/02/2019 - 14:00

NEW YORK, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Hoth Therapeutics Inc. (“Hoth” or the “Company”), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications [...]

Humanigen Study of GM-CSF Neutralization With CAR-T Therapy Selected for Front Cover of Current Edition of ‘blood’®, The Official Journal of the American Society of Hematology (ASH)

15/02/2019 - 14:00

Enhanced anti-tumor activity, improved overall survival, and an exponential increase in CAR-T cell proliferation was observed with GM-CSF neutralization Lenzilumab (an anti-GM-CSF antibody) used in combination with CAR- [...]

CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis

15/02/2019 - 14:00

NEWARK, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for seladelpar [...]

Neuronetics, Inc. Announces Appointment of Dr. Cheryl R. Blanchard to its Board of Directors

15/02/2019 - 14:00

Dr. Blanchard brings more than 30 years of medical device and biotechnology experience to Neuronetics MALVERN, Pa., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical [...]

Repligen to Report Fourth Quarter and Full Year 2018 Financial Results

15/02/2019 - 13:30

- Webcast and Conference Call to Be Held Thursday, February 21, 2019 at 8:30 a.m. EST - WALTHAM, Mass., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report [...]

Myriad Applauds the American Society of Breast Surgeons New Guidelines Recommending Genetic Testing for All People with Breast Cancer

15/02/2019 - 13:05

SALT LAKE CITY, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced its support of the American Society of Breast Surgeons (ASBrS) new [...]

Optinose to Highlight Data at the 2019 AAAAI Annual Meeting in San Francisco

15/02/2019 - 13:00

YARDLEY, Pa., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will [...]